AUSTIN, Texas, Oct. 16, 2025 /PRNewswire/ -- MicroTransponder ®, Inc., a commercial-stage medical technology company and developer of the breakthrough Vivistim ® Paired VNS ™ System for chronic stroke ...
Vivistim is an FDA-approved breakthrough device that works with the brain and body to make stroke rehabilitation therapy and daily activities more effective. AUSTIN, Texas, Jan. 16, 2026 (GLOBE ...
Vivistim is the first and only FDA-approved intervention clinically proven to help chronic ischemic stroke survivors regain 2-3 times more upper extremity function. Vivistim is an implanted device ...
GlobalData on MSN
MicroTransponder receives $65m to advance stroke care with Vivistim
MicroTransponder has received $65m in a Series F financing round, which aims to enhance its stroke care offerings with the ...
TULSA, Okla. — In honor of May being Stroke Awareness Month, PAM Health Rehabilitation Hospital of Tulsa is introducing Green Country to the newest, cutting-edge technology in stroke care, Vivistim.
TAMPA, Fla. (Ivanhoe Newswire) --- Every year, up to a million people suffer a stroke, a number experts say could soar to 200 million by 2050. The leading cause of long-term disability in the U.S., a ...
AUSTIN, Texas, June 16, 2025 /PRNewswire/ -- MicroTransponder®, Inc., a commercial-stage medical technology company and developer of the breakthrough Vivistim® PairedVNS™ System for chronic stroke ...
AUSTIN, Texas, Jan. 31, 2023 /PRNewswire/ -- MicroTransponder®, Inc. announces that the Centers for Medicare and Medicaid Services (CMS) awarded the Vivistim® Paired VNS™ System transitional ...
AUSTIN, Texas, April 25, 2023 /PRNewswire/ -- The FDA-approved Vivistim® Paired VNS™ System won the 2023 Gold Edison Award for being a game-changing solution that helps stroke survivors live fuller ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results